Ceraxon 4ml/500mg ampules №5

TSERAKSON 1gr AMP. 4ml №5

Tserakson has nootropic effect

Indications for use of the drug TSERAKSON:

ischemic stroke (acute phase);

ischemic and hemorrhagic stroke (recovery period);

Traumatic brain injury (acute and recovery period);

cognitive impairment in degenerative and vascular diseases of the brain. disturbance of consciousness in craniocerebral trauma and surgery on the brain,

parkinsonism (with holinolitikami if you can not use L-dopa)

hemiplegia in acute stroke,

acute pancreatitis or exacerbation of chronic pancreatitis,

postoperative acute pancreatitis (in conjunction with inhibitors of proteolytic enzymes).
Pharmacological action: nootropics.
Tsitikolin, as a key precursor of ultrastructural components of the cell membrane (mainly phospholipids), has a broad spectrum of action: helps restore damaged cell membranes, inhibits the action of phospholipases, preventing excessive formation of free radicals and prevents cell death by acting on mechanisms of apoptosis.
In the acute phase of stroke reduces the amount of damaged tissue, improving cholinergic transmission.
With traumatic brain injury reduces the duration of post-traumatic coma and the severity of neurological symptoms.
Tsitikolin improves observed during hypoxia symptoms: memory impairment, emotional lability, lack of initiative, difficulty in performing daily activities and self care.
Tserakson effective in the treatment of cognitive, sensory and motor neurological disorders, degenerative and vascular etiology.
Pharmacokinetics
Since tsitikolin is a natural compound that is contained in the body, classical pharmacokinetic study can not be performed due to the complexity of the quantitative determination of exogenous and endogenous tsitikolina.
In the pharmacokinetic study in healthy volunteers with a destination inside the labeled 14C-tsitikolina almost complete its absorption. Within 5 days after the appointment of the dose in feces excreted <1% of the scheduled dose.
Dosage: In violation of consciousness in head injury or surgery prescribed 100-500 mg Tserakson / drip, iv or im 1-2 times / day. Parkinsonism is usually prescribed to 500 mg 1 time / day for 3-4 weeks w / holinoliticheskimi with drugs. In the treatment of hemiplegia after effects of stroke is assigned 1000 mg of the drug in Tserakson / 1 time / day for 4 weeks. In the treatment of pancreatitis - 1000 mg I / 1 time / day for 2 weeks in combination with inhibitors of proteolytic enzymes.
Contraindications: hypersensitivity to the drug Tserakson
side effects: allergic reactions (rash, itching, etc., may develop shock), insomnia, headache, dizziness, agitation, tremors, numbness in the paralyzed limbs, nausea, decreased appetite, changes in liver function tests, fever , feeling of fever, increased blood pressure)
Special notes: used with caution in patients prone to allergic reactions, newborns, infants and young children. V / m, a drug Tserakson should be limited to a minimum, while avoiding the reintroduction of the drug in the same place
Solution for IV and IM administration transparent, colorless.

 

1 amp.
tsitikolin sodium

1045 mg
equivalent tsitikolinu

1000 mg
Other ingredients: hydrochloric acid or 1 M sodium hydroxide 1 M (up to pH 6.7-7.1), water d / and.
4 ml - ampoules (5) - Packaging Valium planimetric (1) - packs cardboard.